And researchers writing in the New England Journal of Medicine voiced their concerns as well with such drugs as Pfizer s popular Celebrex
In a separate report also released by the medical journal  Dr Eric Topol of the Cleveland Clinic chastises the FDA for not requiring Merck to do studies investigating heart problems with Vioxx when hints of them first appeared years ago  and for allowing the company to blitz consumers with TV ads touting the drug
After some initial evidence that the drug might be linked to cardiac disease  the FDA required Merck to attach an additional warning  which was justified
Others within the agency suggested Graham s conclusion was too strongly worded  given the FDA had not added such warnings to Vioxx labels
He goes on to suggest that Graham rework the study to say  something like This and other studies suggest an increased risk of  acute myocardial infarction with  Vioxx  use and should be considered by prescribers when making individual treatment decisions